Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
16 Jan 13
15-12G
Securities registration termination
30 Mar 12
8-K
Unregistered Sales of Equity Securities
20 Jan 12
10-Q
2011 Q3
Quarterly report
14 Nov 11
10-Q
2011 Q2
Quarterly report
15 Aug 11
8-K
Entry into a Material Definitive Agreement
18 May 11
10-Q
2011 Q1
Quarterly report
16 May 11
10-K
2010 FY
Annual report
30 Mar 11
10-Q
2010 Q3
Quarterly report
12 Nov 10
10-Q
2010 Q2
Quarterly report
13 Aug 10
10-Q
2010 Q1
Quarterly report
14 May 10
10-K
2009 FY
Annual report
29 Mar 10
10-Q
2009 Q3
Quarterly report
13 Nov 09
10-Q
2009 Q2
Quarterly report
13 Aug 09
10-Q
2009 Q1
Quarterly report
14 May 09
DEF 14A
Definitive proxy
29 Apr 09
10-K
2008 FY
Annual report
27 Mar 09
10-Q
2008 Q3
Quarterly report
12 Nov 08
10-Q
2008 Q2
Quarterly report
14 Aug 08
10-Q
2008 Q1
Quarterly report
15 May 08
DEF 14A
Definitive proxy
29 Apr 08
UPLOAD
Letter from SEC
26 Mar 08
CORRESP
Correspondence with SEC
21 Mar 08
UPLOAD
Letter from SEC
26 Feb 08
CORRESP
Correspondence with SEC
15 Feb 08
UPLOAD
Letter from SEC
24 Jan 08
CORRESP
Correspondence with SEC
22 Jan 08
UPLOAD
Letter from SEC
21 Dec 07
10QSB
2007 Q3
Quarterly report (small business)
13 Nov 07
8-K
Other Events
17 Oct 07
10QSB
2007 Q2
Quarterly report (small business)
14 Aug 07
8-K
Departure of Directors or Principal Officers
25 Jun 07
10QSB
2007 Q1
Quarterly report (small business)
15 May 07
DEF 14A
Definitive proxy
30 Apr 07
10QSB
2006 Q3
Quarterly report (small business)
14 Nov 06
8-K
Human Pheromone Sciences Announces License Agreement
22 Aug 06
10QSB
2006 Q2
Quarterly report (small business)
10 Aug 06
10QSB
2006 Q1
Quarterly report (small business)
15 May 06
DEF 14A
Definitive proxy
28 Apr 06
8-K
Other Events
21 Nov 05
Latest ownership filings
No filings